Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Genotype 1”

Showing 20 of 0 results

Not applicableStudy completedNCT01508130
What this trial is testing

An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 672
Testing effectiveness (Phase 2)Study completedNCT01185028
What this trial is testing

A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures

Who this might be right for
Hepatitis C InfectionHIV Infection
National Institutes of Health Clinical Center (CC) 8
Post-approval studies (Phase 4)Study completedNCT01937728
What this trial is testing

Tailored Regimens of PEGASYS® and Ribavirin for Genotype 1 Chronic Hepatitis C Patients Trial (TARGET-1)

Who this might be right for
Hepatitis C
Kaohsiung Medical University Chung-Ho Memorial Hospital 542
Large-scale testing (Phase 3)Study completedNCT01854528
What this trial is testing

Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) for Treatment of Chronic Hepatitis C Infection in Treatment-experienced Adults

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 148
Not applicableStudy completedNCT00728494
What this trial is testing

Compliance of HCV Genotype 1 Infected Patients Receiving PegIntron/Rebetol and a Patient Assistance Program (Study P04671)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC 99
Testing effectiveness (Phase 2)Study completedNCT04246723
What this trial is testing

Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Sofosbuvir in Treatment-naïve Patients With Chronic Hepatitis C Genotype 1

Who this might be right for
Chronic Hepatitis c Genotype 1
R-Pharm 85
Testing effectiveness (Phase 2)WithdrawnNCT00895882
What this trial is testing

Study to Evaluate Different Regimens of Vaniprevir (MK7009) for the Treatment of Chronic Genotype 1 Hepatitis C Virus Infection in Treatment-naive Patients (MK-7009-019)(WITHDRAWN)

Who this might be right for
Chronic Genotype 1 Hepatitis C Virus Infection
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Study completedNCT01389323
What this trial is testing

BMS-790052 (Daclatasvir) Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 448
Testing effectiveness (Phase 2)UnknownNCT01024894
What this trial is testing

Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in Asiatic HCV Patients Resistant to Bitherapy

Who this might be right for
Hepatitis C
Cytheris SA 15
Testing effectiveness (Phase 2)Study completedNCT00606086
What this trial is testing

Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C Infection

Who this might be right for
Genotype 1 Chronic Hepatitis C
GlobeImmune 140
Testing effectiveness (Phase 2)Study completedNCT01994486
What this trial is testing

Open-Label Safety Study of Telaprevir and Sofosbuvir in Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
University of Florida 20
Early research (Phase 1)Study completedNCT00823862
What this trial is testing

Safety Study of SD-101 (a Novel C Type Toll-like Receptor 9 (TLR9) Agonist) for the Treatment of Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C
Dynavax Technologies Corporation 34
Large-scale testing (Phase 3)Study completedNCT02252016
What this trial is testing

Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 159
Large-scale testing (Phase 3)Study completedNCT01292239
What this trial is testing

A Phase III Study of TMC435 in Treatment-naive, Genotype 1, Hepatitis C-infected Patients

Who this might be right for
Hepatitis C, Chronic
Janssen Pharmaceutical K.K. 183
Testing effectiveness (Phase 2)WithdrawnNCT01157975
What this trial is testing

Study the Relationship Between Obesity and Hepatitis C Replication

Who this might be right for
Hepatitis C
University of California, San Diego
Testing effectiveness (Phase 2)Study completedNCT00528528
What this trial is testing

An Open-Label Study of Telaprevir Administered Every 12 or 8 Hours in Combination With One of Two Pegylated Interferons and Ribavirin in Treatment-Naive Genotype 1 Chronic Hepatitis C Participants

Who this might be right for
Chronic Hepatitis C
Tibotec BVBA 166
Large-scale testing (Phase 3)Study completedNCT02074514
What this trial is testing

Safety and Efficacy of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Chronic Genotype 1 or 3 HCV Infection

Who this might be right for
Chronic HCV Infection
Gilead Sciences 117
Testing effectiveness (Phase 2)Study completedNCT01359644
What this trial is testing

Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) in Patients Who Have Previously Not Received the Standard of Care

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 350
Testing effectiveness (Phase 2)Study completedNCT01899092
What this trial is testing

Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Tacere Therapeutics, Inc. 9
Early research (Phase 1)Ended earlyNCT01554085
What this trial is testing

First in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
Alios Biopharma Inc. 78
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation